Le Lézard
Classified in: Health, Science and technology
Subject: ACC

Calliditas Therapeutics' 2020 Annual Report Published


STOCKHOLM, April 27, 2021 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) today announces that the Annual Report for 2020 now is available at the company's website: www.calliditas.com.

This information is information that Calliditas Therapeutics AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 14:30 CET on April 27, 2021.

For further information, please contact:

Marie Galay, IR Manager, Calliditas

Tel.: +44 79 55 12 98 45, email: [email protected]

About Calliditas

Calliditas Therapeutics is a biopharma company based in Stockholm, Sweden focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. Calliditas' lead product candidate, Nefecon, is a proprietary, novel oral formulation of budesonide, an established, highly potent local immunosuppressant, for the treatment of the autoimmune renal disease IgA nephropathy, or IgAN, for which there is a high unmet medical need and there are no approved treatments. Calliditas is running a global Phase 3 study within IgAN and, if approved, aims to commercialize Nefecon in the United States. Calliditas is listed on Nasdaq Stockholm (ticker: CALTX) and the Nasdaq Global Select Market (ticker: CALT). Visit www.calliditas.com for further information.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/calliditas-therapeutics/r/calliditas-therapeutics--2020-annual-report-published,c3334502

The following files are available for download:

https://mb.cision.com/Main/16574/3334502/1408150.pdf

Calliditas AR 2020_EN_

https://mb.cision.com/Public/16574/3334502/83e78aaa2310d2ec.pdf

Annual report 2020 published EN

 

 

 

SOURCE Calliditas Therapeutics


These press releases may also interest you

at 17:50
Breast Tissue Expander Market size is set to grow by USD 282.4 million from 2024-2028, Increasing prevalence of breast cancer boost the market, Technavio
The global breast tissue expander market size is estimated to grow by USD 282.4 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.78%  during the forecast period. Increasing prevalence of breast cancer is...

at 17:50
Sleep Apnea Implants Market size is set to grow by USD 401.75 thousand from 2024-2028, Increasing prevalence of sleep apnea and respiratory disorders boost the market, Technavio
The global sleep apnea implants market size is estimated to grow by USD 401.75 thousand from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 15.2% during the forecast period. Increasing prevalence of sleep apnea and...

at 17:45
Implantable Medical Devices Market size is set to grow by USD 53.5 billion from 2024-2028, Rise in number of people with chronic illnesses to boost the market growth, Technavio
The global implantable medical devices market size is estimated to grow by USD 53.5 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 8.08% during the forecast period. Rise in number of people with chronic...

at 17:35
Transplant Box Market size is set to grow by USD 2.39 billion from 2024-2028, Increasing prevalence of chronic disorders boost the market, Technavio
The global transplant box market size is estimated to grow by USD 2.39 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  10.87%  during the forecast period. Increasing prevalence of chronic disorders is...

at 17:31
BK Virus Infection Market to Witness Surge in Growth During the Study Period (2020-2034) | DelveInsight
DelveInsight's BK Virus Infection Market Insights report includes a comprehensive understanding of current treatment practices, BK virus infection emerging drugs, market share...

at 17:30
Dermatology Devices Market size is set to grow by USD 154.23 billion from 2024-2028, Increasing prevalence of skin disorders to boost the market growth, Technavio
The global dermatology devices market  size is estimated to grow by USD 154.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  9.45%  during the forecast period.  Increasing prevalence of skin...

More news about Health...


News published on and distributed by: